openPR Logo
Press release

Vitreoretinal Surgery Devices Market to Reach USD 4.2 Billion by 2034

09-24-2025 12:56 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Vitreoretinal Surgery Device

Vitreoretinal Surgery Device

Vitreoretinal surgery is a specialized field of ophthalmic surgery focused on treating diseases affecting the retina, vitreous body, and macula of the eye. The most common indications for vitreoretinal surgery include retinal detachment, macular holes, diabetic retinopathy, and vitreous hemorrhages. The goal of these surgeries is to restore or preserve vision and address complications caused by retinal diseases that threaten eyesight.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72307

The global vitreoretinal surgery devices market is growing as surgical techniques and diagnostic technologies continue to advance. The development of minimally invasive surgical instruments, high-precision lasers, and surgical robots is transforming the treatment landscape, making procedures safer, faster, and more effective.

Market Overview
• Market Size (2024): USD 1.8 billion
• Forecast (2034): USD 4.2 billion
• CAGR (2025-2034): 8.8%

Key Highlights:
• Increasing global prevalence of retinal diseases and diabetic retinopathy driving demand for vitreoretinal surgeries.
• Rising adoption of minimally invasive techniques and precision instruments.
• Growing use of robot-assisted surgeries and AI-guided systems in complex retinal procedures.
• Expansion of retinal specialty centers and ophthalmic surgery training improving procedure access and quality.

Segmentation Analysis
By Device Type:
• Vitrectomy Systems
o The most common device used for removal of the vitreous gel and repair of retinal tears.
o Includes surgical probes, vitrectomy cutters, infusion systems, and light sources.
• Laser Systems
o Argon and diode lasers used for retinal photocoagulation, commonly used for diabetic retinopathy and macular edema.
o Femtosecond lasers gaining traction in cataract and retinal surgeries for precision cutting.
• Pneumatic Retinopexy Devices
o Used for treating retinal detachment by applying gas or air to the retina.
• Surgical Instruments
o Specialized forceps, scissors, and scissors used in delicate vitreoretinal surgeries.
• Surgical Robots
o Next-generation robot-assisted surgery systems for high-precision retinal surgeries.

By End Use:
• Hospitals & Specialty Eye Clinics
• Ambulatory Surgical Centers (ASCs)
• Research & Academic Institutes
• Ophthalmic Surgery Centers

By Procedure Type:
• Retinal Detachment Surgery
o The leading application of vitreoretinal surgery devices for repairing retinal tears or detachment.
• Diabetic Retinopathy Surgery
o Surgical interventions to prevent vision loss from diabetic retinopathy, including panretinal photocoagulation.
• Macular Hole Surgery
o Treatment for macular hole formation, involving vitrectomy and gas tamponade.
• Vitreous Hemorrhage Surgery
o Removal of blood in the vitreous cavity to restore vision, commonly in diabetic retinopathy cases.

Segmentation Summary:
Vitrectomy systems dominate the market, but laser systems and robot-assisted surgeries are rapidly growing, driven by advances in precision and automation.

Explore Full Report here: https://exactitudeconsultancy.com/reports/72307/vitreoretinal-surgery-devices-market

Regional Analysis
North America
• Largest market (~40% share in 2024).
• High adoption of advanced surgical devices and robot-assisted surgeries.
• Expanding healthcare infrastructure and reimbursement for diabetic retinopathy and retinal surgeries.
Europe
• ~30% share.
• Germany, UK, and France leading adoption of high-precision retinal devices and laser treatments.
• Increasing focus on early detection and minimally invasive procedures.
Asia-Pacific
• Fastest-growing region, CAGR ~9.5%.
• China, India, and Japan leading in market expansion due to rising diabetic populations and healthcare infrastructure development.
• Growing demand for retinal surgery training and advanced surgical devices.
Latin America
• Brazil and Mexico improving ophthalmic surgery infrastructure and access to advanced retinal treatments.
Middle East & Africa
• GCC countries investing in eye care infrastructure.
• Sub-Saharan Africa faces significant gaps in specialized retinal care and diagnostic equipment.
Regional Summary:
North America and Europe lead in adoption of high-tech devices, but Asia-Pacific will experience the highest growth due to expanding diabetic populations, retinal disease burden, and healthcare investments.

Market Dynamics
Key Growth Drivers:
• Increasing prevalence of retinal diseases (e.g., diabetic retinopathy, macular degeneration, retinal detachment) due to aging populations and diabetes.
• Technological advancements in minimally invasive surgeries, such as vitrectomy, femtosecond lasers, and robot-assisted surgeries.
• Growing focus on early intervention, precision treatment, and AI-guided diagnostics for retinal diseases.
• Increase in specialty eye care centers and ophthalmic surgical training programs improving accessibility to advanced treatments.

Key Challenges:
• High cost of advanced vitreoretinal surgery systems and robotic surgery platforms.
• Regulatory hurdles and the time required for new technology approval.
• Limited access to advanced surgical devices in low- and middle-income countries.
• Post-surgical complications such as infection, macular edema, and increased intraocular pressure (IOP).

Latest Trends:
• AI-based surgical platforms and diagnostic tools for real-time analysis and enhanced precision.
• Increasing adoption of robotic surgery for retinal and cataract procedures, allowing for greater accuracy and reduced recovery time.
• Portable vitreoretinal surgery devices for use in rural and underserved areas.
• Growing prevalence of myopia driving the need for advanced retinal surgery solutions.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72307

Competitor Analysis
Major Players in the Market:
• Alcon Inc. (retinal surgical equipment, laser systems)
• Johnson & Johnson Vision (retinal surgery devices)
• Bausch + Lomb (retinal surgery and diagnostic products)
• Carl Zeiss Meditec AG (ophthalmic lasers and surgical equipment)
• Topcon Corporation (retinal diagnostic equipment and surgical tools)
• Nidek Co., Ltd. (retinal imaging devices, laser systems)
• Medtronic PLC (robot-assisted surgery systems, precision surgical tools)
• Synergetics USA, Inc. (vitreoretinal surgical systems)
• Iridex Corporation (retinal lasers and surgical devices)

Competitive Summary:
Alcon, Johnson & Johnson Vision, and Bausch + Lomb are the leaders in surgical devices and retinal imaging systems. Medtronic PLC is advancing with robot-assisted surgeries and precision tools, while Carl Zeiss Meditec and Topcon are well-regarded for retinal lasers and surgical equipment. Iridex and Synergetics USA focus on specialized laser solutions for retinal surgeries.

Conclusion
The Vitreoretinal Surgery Devices Market, valued at USD 1.8 billion in 2024, is projected to reach USD 4.2 billion by 2034, expanding at a CAGR of 8.8%.

Key Takeaways:
• Minimally invasive surgeries like vitrectomy and laser procedures dominate today's market.
• Robot-assisted surgery and AI-powered diagnostic tools are emerging as the next frontier in precision retinal surgery.
• Asia-Pacific will experience the highest growth due to rising diabetic populations and increasing healthcare investments.
• The market is moving toward smaller, portable surgical devices and early detection solutions for retinal diseases.

Over the next decade, the vitreoretinal surgery devices market will shift towards minimally invasive, precision-driven treatments, improving patient outcomes and reducing the risks associated with traditional retinal surgeries.

This report is also available in the following languages : Japanese (硝子体網膜手術デバイス市場), Korean (유리체망막 수술 장치 시장), Chinese (玻璃体视网膜手术设备市场), French (Marché des dispositifs de chirurgie vitréo-rétinienne), German (Markt für Geräte zur vitreoretinalen Chirurgie), and Italian (Mercato dei dispositivi per la chirurgia vitreoretinica), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72307/vitreoretinal-surgery-devices-market#request-a-sample

Our More Reports:

Clinical Trial Patient Recruitment Services Market
https://exactitudeconsultancy.com/reports/73139/clinical-trial-patient-recruitment-services-market

Drug Delivery Technologies Market
https://exactitudeconsultancy.com/reports/73140/drug-delivery-technologies-market

ADME Toxicology Testing Market
https://exactitudeconsultancy.com/reports/73141/adme-toxicology-testing-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vitreoretinal Surgery Devices Market to Reach USD 4.2 Billion by 2034 here

News-ID: 4195851 • Views:

More Releases from Exactitude Consultancy

Myopia Treatment Devices Market to Reach USD 4.6 Billion by 2034
Myopia Treatment Devices Market to Reach USD 4.6 Billion by 2034
Myopia, commonly known as nearsightedness, is a refractive error in which distant objects appear blurry while near objects are clear. It is caused by an elongated eyeball or excessive curvature of the cornea, resulting in the light focusing in front of the retina. The condition is becoming increasingly prevalent worldwide, especially in younger populations, as a result of extended screen time, lack of outdoor activities, and genetic predisposition. Download Full PDF
BRIC Biopsy Devices Market Forecast to Grow at 9.1% CAGR, Reaching USD 7.4 Billion by 2034
BRIC Biopsy Devices Market Forecast to Grow at 9.1% CAGR, Reaching USD 7.4 Billi …
Introduction Biopsy devices are essential tools in modern healthcare, particularly in cancer detection, staging, and treatment planning. As the global cancer burden rises, early detection has become more critical than ever. In the BRIC nations - Brazil, Russia, India, and China - the demand for biopsy devices is accelerating due to demographic transitions, increasing awareness, and expanding healthcare access. These four countries collectively represent more than 40% of the global population, making
Asia-Pacific Biopsy Devices Market Projected to Grow at 8.9% CAGR, Reaching USD 5.4 Billion by 2034
Asia-Pacific Biopsy Devices Market Projected to Grow at 8.9% CAGR, Reaching USD …
Introduction Biopsy procedures are central to modern medicine, especially in the detection and management of cancer. As the gold standard for diagnosing malignancies, biopsies allow for tissue sampling and pathological analysis to confirm disease presence and determine treatment strategies. In Asia-Pacific, where cancer cases are rapidly increasing due to demographic shifts, lifestyle changes, and environmental factors, the demand for biopsy devices is surging. The Asia-Pacific Biopsy Devices Market has emerged as a
Ophthalmic Ultrasound Devices Market to Reach USD 3.1 Billion by 2034
Ophthalmic Ultrasound Devices Market to Reach USD 3.1 Billion by 2034
Ophthalmic ultrasound devices are crucial tools in diagnostic imaging for eye diseases such as retinal detachment, cataracts, glaucoma, and macular degeneration. These devices provide non-invasive, real-time imaging, making them indispensable in ophthalmic practices. The technology helps in visualizing internal eye structures, measuring intraocular pressure (IOP), and detecting abnormalities that affect vision. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72303 With the global increase in eye-related disorders, such as age-related macular

All 5 Releases


More Releases for Surgery

Dental Surgery Conference | Dental Surgery Congress | Chicago | USA
Dental Surgery 2024We are delighted to invite dental professionals from all over the world to join us for an exceptional and comprehensive dental conference the 40th International Conference on Dental Surgery and Medicine. This event is designed to facilitate knowledge sharing, networking, and exploration of the latest advancements in the field of dentistry. Theme: "A better life starts with a beautiful smile" Date: June 06-07, 2024 Venue: Chicago,USA Chicago,USA CHICAGO Dental Surgery 2024We are delighted to
Intraoperative Neuromonitoring Market Size to Hit Valuation of $4.90 Billion by …
IONM would improve intraoperative decision-making, by guiding a surgeons hands during surgery to reduce potential neurological risk. This benefits patients with a better surgical outcome and reduces a surgeons liability to a great extent. Global Intraoperative Neuromonitoring (IONM) Market was valued at $3,036 million in 2015, and is projected to reach $4,900 million by 2022, growing at a CAGR of 7% from 2016 to 2022, according to a new report published
Hemostats Market Research Insights by Major Applications Survey on cardiovascula …
Hemostasis is the course of blood clotting. Blood clotting plays a vital role in various surgeries by achieving positive outcomes with the reduction of blood loss. This clotting process reduces the surgery time and the need for blood transfusion. Thus, hemostats are surgical instruments used to regulate the bleeding during surgery. Hemostats are also used for oozing out venomous bleeds, bone bleeding, and others. The scope of hemostats is growing rapidly
Europe Data for Surgeries by Surgery Type (Hip Implant, Major Peritoneal Surgery …
The number of hip implant surgeries, major peritoneal surgeries, thoracic surgeries, and ENT surgeries along with the surgeries for central nervous system (CNS), in Europe were valued at 35,860 thousand procedures in 2016 and is projected to reach 41,818 thousand procedures by 2023. The study includes number of hip implants and major peritoneal, thoracic, CNS, and ENT surgeries performed in Europe. In addition, the report includes other relevant details for
Surgical Robotics Market Growth Study by Component [Systems, Accessories and Ser …
Robotic surgery is a type of minimally invasive surgery which utilizes robotics for performing surgical procedures. These robotic systems are operated by surgeons and consists of miniaturized surgical instruments which are mounted on robotic arms, thus allowing surgeons to perform the surgeries precisely. The global surgical robotics market was valued at $56,294.9 million in 2017, and is expected to reach $98,737.0 million by 2024 at a CAGR of 8.5% during
Surgical Robotics Market Report 2018: Segmentation by Component (Systems, Access …
Global Surgical Robotics market research report provides company profile for Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Intuitive Surgical, Inc., KUKA AG, Stryker Corporation (MAKO Surgical Corp.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth